B of A Securities Downgrades Hill-Rom Holdings to Neutral, Announces $130 Price Target

B of A Securities analyst Bob Hopkins downgrades Hill-Rom Holdings (NYSE:HRC) from Buy to Neutral and announces $130 price target.

B of A Securities analyst Bob Hopkins downgrades Hill-Rom Holdings (NYSE:HRC) from Buy to Neutral and announces $130 price target.

Total
0
Shares
Related Posts
Read More

Where Stem Stands With Analysts

Over the past 3 months, 5 analysts have published their opinion on Stem (NYSE:STEM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

STEM

Read More

AstraZeneca to Present New Data Advancing Its Ambition to Redefine Care at the 2022 San Antonio Breast Cancer Symposium; Twelve Medicines and Potential New Medicines Will Be Featured in 55 Presentations

Data will show clinical opportunity in HR-positive advanced breast cancer for potential first-in-class AKT inhibitor capivasertib and next-generation oral SERD camizestrant. Enhertu data will reinforce potential to set new standards in HER2-targetable disease. Data for antibody drug conjugate datopotamab deruxtecan will demonstrate potential in HR-positive and triple-negative breast cancer.

AZN